It’s amazing they even managed to do it again this time around.
that's the bottom line
Sandoz have completed their own forensic due diligence on tpm with more than an adequate amount of data available to them across the lifecycle development of the product... the terms of the agreement extend beyond the outcome of the phase 3 synthetic cbd + tpm
it would seem they find value attached to tpm - based on that view they also find potential value in the outcome of the interim analysis of synthetic cbd + tpm
that is the punt - you either back in the agreement that supports that 'value' case or you don't
on that basis Sandoz by agreement is a considerable risk mitigation of Avechos' work to date
that's all I consider here - discussions on previous iterations of the company or failed / unfulfilled agreements hold no sway at this point - it is a distraction
red or black as always
AVE Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)